What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination? (Q48708508)
Jump to navigation
Jump to search
scientific article published on 2 November 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination? |
scientific article published on 2 November 2005 |
Statements
1 reference
What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination? (English)
1 reference
Roxy Senior
1 reference
Gavin I W Galasko
1 reference
Sophie C Barnes
1 reference
Paul Collinson
1 reference
Avijit Lahiri
1 reference
2 November 2005
1 reference
1 reference
27
1 reference
2
1 reference
193-200
1 reference
Identifiers
1 reference
1 reference